ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,299, issued on March 31, was assigned to The General Hospital Corp. (Boston).

"Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)" was invented by J. Keith Joung (Winchester, Mass.) and Benjamin Kleinstiver (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Engineered CRISPR from Prevotella and Francisella 1 (Cpf1) nucleases with altered and improved target specificity and their use in genomic engineering, epigenomic engineering, genome targeting, genome editing, and in vitro diagnostics."

The patent was filed on Oct. 12, 2021, under Application No. 17/450,593.

*For further information, including images, charts and tables, please vis...